Text Size
35 studies found for:    cannabidiol

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Cannabidiol for Inflammatory Bowel Disease
Conditions: Crohn's Disease;   Ulcerative Colitis
Interventions: Drug: cannabidiol;   Drug: placebo in drops
2 Recruiting Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
Condition: Graft Versus Host Disease
Intervention: Drug: Cannabidiol
3 Completed Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse
Condition: Opiate Addiction
Interventions: Drug: Cannabidiol;   Drug: Fentanyl
4 Recruiting Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation
Condition: Graft Versus Host Disease
Intervention: Drug: Oral Cannabidiol
5 Completed Study to Assess the Effect of Cannabidiol on Liver Fat Levels in Subjects With Fatty Liver Disease.
Condition: Fatty Liver
Intervention: Drug: Cannabidiol
6 Not yet recruiting Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Condition: Smoking, Marijuana
Intervention: Drug: cannabidiol
7 Recruiting Acute and Short-term Effects of Cannabidiol Administration on Cue-induced Craving in Drug-abstinent Heroin Dependent Subjects
Condition: Opiate Addiction
Interventions: Drug: Cannabidiol;   Drug: Placebo
8 Completed A Clinical Trial on the Antipsychotic Properties of Cannabidiol
Conditions: Schizophrenia;   Psychotic Disorders
Interventions: Drug: Placebo/Cannabidiol;   Drug: Cannabidiol/Placebo
9 Recruiting The Effects of Cannabidiol and ∆-9-THC in Humans
Condition: Healthy
Interventions: Drug: Cannabidiol;   Drug: Delta-9-THC;   Drug: Placebo
10 Completed Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
Condition: Schizophrenia
Interventions: Drug: Cannabidiol;   Drug: Amisulpride
11 Recruiting Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Cannabidiol;   Drug: Placebo
12 Not yet recruiting Evaluation Study of New Compounds With Potential Use in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Sitagliptin;   Drug: intranasal Insulin;   Drug: Cannabidiol
13 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
14 Completed
Has Results 		A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.
Conditions: Palliative Care;   Pain;   Cancer
Interventions: Drug: Sativex Low Dose;   Drug: Sativex Medium Dose;   Drug: Sativex High Dose
15 Completed
Has Results 		An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Drug: GW-1000-02;   Drug: Placebo
16 Completed
Has Results 		An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: GW-1000-02
17 Completed
Has Results 		A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: GW-1000-02
18 Completed
Has Results 		A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
Conditions: Detrusor Overactivity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
19 Completed
Has Results 		A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin
Conditions: Pain;   Multiple Sclerosis
Interventions: Drug: GW-1000-02;   Drug: Placebo
20 Recruiting Fixed or Self-Titrated Dosages of Sativex on Cannabis Users
Condition: Cannabis Dependence
Interventions: Drug: Sativex;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
† Indicates status has not been verified in more than two years